- ￥95 - 186
- TargetMol
- T2941
- 2026年07月07日
企业认证
相关产品推荐更多 >
万千商家帮你免费找货
0 人在求购买到急需产品
- 详细信息
- 文献和实验
- 技术资料
- CAS号：
66-84-2
- 规格：
1mLx10mM(inDMSO)/2g/5g
| 规格： | 1mLx10mM(inDMSO) | 产品价格： | ￥95.0 |
|---|---|---|---|
| 规格： | 2g | 产品价格： | ￥126.0 |
| 规格： | 5g | 产品价格： | ￥186.0 |
Product Introduction
Bioactivity
| 名称 | Glucosamine hydrochloride |
| 描述 | Glucosamine hydrochloride (Chitosamine hydrochloride) is commonly used as a treatment for osteoarthritis, although its acceptance as a medical therapy varies. |
| 存储条件 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year Shipping with blue ice/Shipping at ambient temperature. |
| 溶解度 | 10% DMSO+40% PEG300+5% Tween 80+45% Saline : 2 mg/mL (9.28 mM), Sonication is recommended. H2O : 250 mg/mL (1159.39 mM), Sonication is recommended. DMSO : 55 mg/mL (255.07 mM), Sonication is recommended. |
| 关键字 | ReactiveOxygenSpecies | Reactive Oxygen Species | Inhibitor | inhibit | Hypoxia-inducible factors | HIFs | HIFProlylHydroxylase | HIF-PH | HIF/HIFProlylHydroxylase | HIF/HIF Prolyl-Hydroxylase | HIF/HIF ProlylHydroxylase | HIF Prolyl-Hydroxylase | HIF ProlylHydroxylase | HIF | Glucosamine hydrochloride | Glucosamine | EndogenousMetabolite | Endogenous Metabolite | D-Glucosamine Hydrochloride | Chitosamine Hydrochloride | Chitosamine | Autophagy |
| 相关产品 | Guanidine hydrochloride | Glycerol | Aceglutamide | Malic acid | DL-Lysine | Sucrose | Hemin | Nicotinamide riboside malate | Gluconate Calcium | Thymidine | D(+)-Raffinose pentahydrate | Ethyl linoleate |
| 相关库 | Bioactive Compound Library | Anti-Cancer Approved Drug Library | Bioactive Compounds Library Max | Oxidation-Reduction Compound Library | Anti-Cancer Metabolism Compound Library | Anti-Fibrosis Compound Library | Anti-Aging Compound Library | Cosmetic Ingredient Compound Library | Immunology/Inflammation Compound Library | Drug Repurposing Compound Library | Saccharide and Glycoside Natural Product Library | Anti-Cancer Drug Library |
风险提示：丁香通仅作为第三方平台，为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全，合理判断，谨慎选购商品，商家和用户对交易行为负责。对于医疗器械类产品，请先查证核实企业经营资质和医疗器械产品注册证情况。
文献和实验.1 14.9 14.7 14.6 14.5 14.5 14.4 14.3 14.2 14.2 14.1 14.0 13.9 3 4 10.6 9.98 9.60 9.36 9.20 9.07 8.98 8.90 8.84 8.75 8.66 8.56 8.46 8.36 8.26 4 5 8.43 7.76 7.39 7.16 6.98 6.85 6.76 6.68 6.62 6.52 6.43 6.33 6.23 6.12 6.01 5 6 7.26 6.60 5.23
99 66 02 79 54 10 57 60 86 32 44 09 47 27 96 54 49 17 46 09 62 90 52 84 77 27 08 02 73 43 28 11 18 18 07 92 46 44 17 16 58 09 79 83 86 19 62 06 76 50 03 10 55 23 64 05 05 12 26 62 38 97 75 84 16 07 44 99 83 11 46 32 24 20 14 85 88 45 10 93 72 88 71
8.79 8.74 8.71 8.69 8.67 8.66 3 4 7.71 6.94 6.59 6.39 6.26 6.16 6.09 6.04 6.00 5.96 5.91 5.87 5.84 5.82 5.80 4 5 6.61 5.79 5.41 5.19 5.05 4.95 4.88 4.82 4.77 4.74 4.68 4.64 4.60 4.58 4.56 5 6 5.99 5.14 4.76 4.53 4.39 4.28 4.21 4.15 4.10 4.06 4.00
技术资料暂无技术资料 索取技术资料
